Skip to main content
. 2017 Aug;18(4):341–359. doi: 10.2174/1389202918666170307161643

Table 8.

Molecular genetic analysis of MMR mutation negative tumours [16].

__ MMR Mutation Negative Tumours %
MSS 52 out of 52 100%
APC mutation 10 out of 52 19.2%
Nuclear beta-catenin 16 out of 44 36%
Membranous beta-catenin 28 out of 44 63%
APC mutation 9 out of 16
(of tumours with nuclear beta-catenin)
56%
(of tumours with nuclear beta-catenin)